Meloxicam Targets COX-2/NOX1/NOX4/Nrf2 Axis to Ameliorate the Depression-like Neuropathology Induced by Chronic Restraint Stress in Rats

Meloxicam has shown significant neuroprotection in experimental models of stroke, Alzheimer’s disease, and Parkinson’s disease. However, the potential of meloxicam to treat depression-like neuropathology in a chronic restraint stress (CRS) model and the associated molecular changes has been insuffic...

Descripción completa

Detalles Bibliográficos
Autores principales: Arab, Hany H., Khames, Ali, Mohammad, Mostafa K., Alsufyani, Shuruq E., Ashour, Ahmed M., El-Sheikh, Azza A. K., Darwish, Hany W., Gad, Amany M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304337/
https://www.ncbi.nlm.nih.gov/pubmed/37375795
http://dx.doi.org/10.3390/ph16060848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304337/
https://www.ncbi.nlm.nih.gov/pubmed/37375795
http://dx.doi.org/10.3390/ph16060848

Ejemplares similares